Stay updated with breaking news from Michaela Dinerman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) CEO Brian Lian sold 79,336 shares of the firm’s stock in a transaction on Thursday, April 13th. The shares were sold at an average price of $18.45, for a total value of $1,463,749.20. Following the sale, the chief executive officer now directly owns 2,307,963 shares of the company’s […]
Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) CFO Greg Zante sold 56,295 shares of the stock in a transaction on Tuesday, April 11th. The stock was sold at an average price of $18.00, for a total transaction of $1,013,310.00. Following the completion of the sale, the chief financial officer now directly owns 149,279 shares of […]
Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) reached a new 52-week high on Tuesday . The company traded as high as $18.03 and last traded at $17.67, with a volume of 1964250 shares trading hands. The stock had previously closed at $16.94. Analyst Ratings Changes VKTX has been the topic of several recent research reports. […]
Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) CEO Brian Lian sold 67,970 shares of the stock in a transaction dated Friday, March 31st. The shares were sold at an average price of $17.45, for a total value of $1,186,076.50. Following the completion of the transaction, the chief executive officer now directly owns 2,254,963 shares in […]
Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) CEO Brian Lian sold 22,000 shares of the business’s stock in a transaction dated Monday, April 3rd. The stock was sold at an average price of $17.85, for a total value of $392,700.00. Following the transaction, the chief executive officer now directly owns 2,232,963 shares of the company’s […]